spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 3. CAP2b- and Drosokinin-stimulated fluid transport are inhibited in itpr mutants. Fluid transport assays were performed on intact tubules as described in Fig. 1 for the following lines: Oregon R (control), itprXR12/+, itpr90B.0/+, itpr1664/+, itpr1664/itprXR12, itpr1664/itpr90B.0, itpr1664/itpr1664 and itprWC361/itprUG3. Either (A) 10-7 moll-1 CAP2b or (B) 10-7 moll-1 Drosokinin were added at 30 min, and transport rates were measured for a further 30 min. No change in basal secretion rate was observed in itpr mutants. Furthermore, kinetics of the fluid secretion response in all lines were similar (data not shown). To aid comparison between stimulated transport rates, data are expressed as the % stimulation of secretion [(maximal stimulated rates minus the mean of three basal secretion rate readings)/(mean basal rate)x100% ± S.E.M.; N=15-20] upon stimulation with CAP2b or Drosokinin. Stimulated fluid transport rates that are significantly different from wild type are denoted by * (P<0.05, Student's t-test, unpaired samples).





Right arrow Return to article